Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin-II Antagonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin-II Antagonist

Published:1995-09 Issue:3 Volume:13 Page:230-250
ISSN:0897-5957
Container-title:Cardiovascular Drug Reviews
language:en
Short-container-title:Cardiovasc Drug Reviews

Author:

Criscione Leoluca,Bradley William A.,Bühlmayer Peter,Whitebread Steve,Glazer Robert,Lloyd Peter,Mueller Philipp,Gasparo Marc

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1527-3466.1995.tb00305.x/fullpdf

Reference49 articles.

1. Patent Update: Angiotensin-II Antagonists: Patent Activity since the Discovery of DuP-753

2. Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series

3. Dopamine selectively inhibits aldosterone responses to angiotensin II in humans.

4. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation and Characterization of Buccal Films Containing Valsartan with Additional Support from Image Analysis;AAPS PharmSciTech;2023-03-03

2. Genotoxicity evaluation of a valsartan-related complex N-nitroso-impurity;Regulatory Toxicology and Pharmacology;2022-10

3. Selection of the candidate compound at an early stage of new drug development: retrospective pharmacokinetic and metabolic evaluations of valsartan using common marmosets;Xenobiotica;2022-06-03

4. Stability‐indicating reversed‐phase‐HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality‐by‐design approach;Biomedical Chromatography;2021-10

5. Nanostructured Valsartan Microparticles with Enhanced Bioavailability Produced by High-Throughput Electrohydrodynamic Room-Temperature Atomization;Molecular Pharmaceutics;2021-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3